METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE Russian patent published in 2017 - IPC A61K31/145 A61P9/10 A61P43/00 

Abstract RU 2638807 C2

FIELD: pharmacology.

SUBSTANCE: following are proposed: method for treating a subject suffering from ischemic damage or an acute ischemic event, comprising administering cysteamine, cystamine or a salt thereof, simultaneously with or immediately after the ischemic event, in an amount effective to reduce the ischemic damage, wherein the subject does not suffer from hypercholesterolemia or diabetes of II type, where the administration of cysteamine, cystamine or a salt thereof leads to an increase in adiponectin level with low molecular weight (LMW) (versions) in subjects; a method for increasing (versions) adiponectin levels with LMW in the mentioned patient group comprising contacting the subject with an effective amount of cysteamine, cystamine or a salt thereof (versions); the use of cysteamine, cystamine or a salt thereof in the manufacture of a medicament in the above mentioned treatment of a subject suffering from the acute ischemic event and not suffering from hypercholesterolemia or diabetes of II type.

EFFECT: levels of all adiponectin multimers are increased, within 1 hour after cysteamine exposure in the blood serum, LMW of adiponectin was rapidly and significantly increased, cysteamine administration 2 hours before the ischemic stroke significantly reduced the infarction area and the number of ischemic damages.

28 cl, 18 dwg, 2 tbl, 3 ex

Similar patents RU2638807C2

Title Year Author Number
METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH USING CYSTEAMINE PRODUCTS 2008
  • Dokhil Randzhan
  • Shnajder Dzherri
RU2498795C2
Oxy133 OXYSTEROL ANALOGUE INDUCTS OSTEOGENESIS AND SIGNAL WAY HEDGEHOG AND INHIBITED LIPOGENESIS 2013
  • Parkhami Farkhad
  • Yung Majkl E.
  • Stepenbek Frenk
RU2632191C2
MATERIALS AND METHODS FOR METABOLISM MODULATION 2005
  • Chan' Bill Piu
  • Vong Gari Kvan Po
  • Sjuj Tszin'Sjan'
  • Chi Fransish
RU2387445C2
METHOD OF PROPHYLAXIS OF NEPHROTOXICITY INDUCED BY CYCLOSPORINE OR TACROLIMUS 1998
  • Strajker Gehri Eh.
  • Strajker Lillian
  • Kortrajt Kennet Kh.
RU2191020C2
THERAPEUTIC COMPOUNDS AND COMPOSITIONS 2019
  • Hayward, Neil J.
  • Chenard, Bertrand L.
  • Xu, Yuelian
  • Dorow, Roberta L.
  • Matison, Michael E.
  • Kolchinski, Alexander
  • Fornicola, Richard
RU2813780C2
CYSTEAMINE DIOXYGENASE-RESISTANT ANALOGUES OF CYSTEAMINE AND THEIR USE 2016
  • Zankel, Todd, C.
  • Unitt, John
  • Phillips, Timothy
  • Gourdet, Benoit
  • Duffy, Loma
RU2766579C2
METHOD OF REDUCING DEMAGE TO NERVOUS CELLS 2007
  • Poulsen Dehvid Dzh.
  • Rau Tomas Frederik
RU2464977C2
SYSTEM DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR TREATMENT OF CARDIOVASCULAR AND OTHER DISEASES 2013
  • Khemmond Kh. Kerk
  • Gao Mej Khua
RU2642605C2
ANALOGUES OF CYSTAMINE, USED FOR PARKINSON'S DISEASE TREATMENT 2012
  • Sichetti Francheska
  • Ruillard Klaudi
  • Kalon Frederik
RU2630583C2
COMPOSITIONS AND METHODS FOR TREATING DIABETES 2004
  • Chan' Piu
  • Vong Gari Kvan Po
  • Sjuj Tszin'Sjan'
  • Chi Fransish
RU2367423C2

RU 2 638 807 C2

Authors

Dokhil Randzhan

Fillips Syuzan A.

Dates

2017-12-15Published

2012-11-21Filed